These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11535542)

  • 1. Evaluation of epithelial cell proliferation rate in normal-appearing colonic mucosa as a high-risk marker for colorectal cancer.
    Akedo I; Ishikawa H; Ioka T; Kaji I; Narahara H; Ishiguro S; Suzuki T; Otani T
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):925-30. PubMed ID: 11535542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial.
    Sandler RS; Baron JA; Tosteson TD; Mandel JS; Haile RW
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):653-6. PubMed ID: 10919733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients.
    Bostick RM; Fosdick L; Grandits GA; Lillemoe TJ; Wood JR; Grambsch P; Louis TA; Potter JD
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1011-9. PubMed ID: 9419396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel.
    Scalmati A; Roncucci L; Ghidini G; Biasco G; Ponz de Leon M
    Cancer Res; 1990 Dec; 50(24):7937-41. PubMed ID: 2253235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of the epithelial cell proliferative compartment and frequency of adenomatous polyps in the colon correlate with the strength of family history of colorectal cancer.
    Gerdes H; Gillin JS; Zimbalist E; Urmacher C; Lipkin M; Winawer SJ
    Cancer Res; 1993 Jan; 53(2):279-82. PubMed ID: 8417821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of colorectal ornithine decarboxylase activity in patients with colon cancer, a family history of nonpolyposis hereditary colorectal cancer, and adenomas.
    Love RR; Surawicz TS; Morrissey JF; Verma AK
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):195-8. PubMed ID: 1306105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk.
    Biasco G; Paganelli GM; Santucci R; Brandi G; Barbara L
    J Cell Biochem Suppl; 1994; 19():55-60. PubMed ID: 7823606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki67 immunohistochemical evaluation in colorectal cancer and normal colonic mucosa. Possible clinical applications.
    Berenzi A; Benetti A; Bertalot G; Rodolfi A; Portolani N; Giulini SM; Pulcini G; Vinco A; Tiberio G
    Pathologica; 1992; 84(1090):155-63. PubMed ID: 1437304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms.
    Sidelnikov E; Bostick RM; Flanders WD; Long Q; Seabrook ME
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2965-73. PubMed ID: 19861524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.
    Krishnan K; Ruffin MT; Normolle D; Shureiqi I; Burney K; Bailey J; Peters-Golden M; Rock CL; Boland CR; Brenner DE
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):447-53. PubMed ID: 11352853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry and in vitro tritiated thymidine labeling in normal rectal mucosa of patients at high risk of colorectal cancer.
    Paganelli GM; Lalli E; Facchini A; Biasco G; Santucci R; Brandi G; Barbara L
    Am J Gastroenterol; 1994 Feb; 89(2):220-4. PubMed ID: 8304307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic effects of deoxycholic acid and butyrate on epithelial cell proliferation in the proximal and distal human colon.
    Bartram HP; Englert S; Scheppach W; Dusel G; Richter F; Richter A; Kasper H
    Z Gastroenterol; 1994 Jul; 32(7):389-92. PubMed ID: 7975774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients.
    Rulyak SJ; Lieberman DA; Wagner EH; Mandelson MT
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):470-6; quiz 407. PubMed ID: 17270502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.
    Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R
    Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
    Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
    J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.